Skip to content
OpenCapital
Collapse sidebar
Watchlist
Screener
Filings
Earnings
Charts
Collapse sidebar
Screener
Inhibrx Biosciences, Inc.
INBX
Other General and Administrative Expense
Other General and Administrative Expense at other companies
FS KKR Capital Corp.
FSK
$6M
+20.0%
Sixth Street Specialty Lending
TSLX
$1.37M
+2.4%
Blackstone Secured Lending Fund
BXSL
$1.01M
-5.4%
Blue Owl Capital
OBDC
$3.09M
-23.4%
Axos Financial
AX
$16.37M
+139%
Blue Owl Technology Finance
OTF
$3.29M
+119%
Segments
By segment
See full
Reportable Segment
$1.93M
-75.2%
Other financials
Income statement
See full
Revenue
-
-100%
Operating income
-$30.9M
+27.9%
Net income
-$33.4M
+22.8%
EPS (diluted)
-$2.15
+23.2%
Balance sheet
See full
Cash & equivalents
$161.7M
-25.3%
Total debt
$180.9M
+69.8%
Total equity
-$21.0M
-122%
Total assets
$184.0M
-24.2%
Cash flow
See full
Operating cash flow
-$38.0M
-5.9%
CapEx
-
-100%
Free cash flow
-$38.0M
-5.9%
Valuation
See full
Market cap
$1.3B
+320%
Enterprise value
$1.32B
+474%
Profitability
See full
Operating margin
-10,386.5%
-5,025pp
Net margin
-10,773.5%
-878,492pp
FCF margin
-9,986.5%
-4,727pp
Returns & leverage
See full
Return on equity
-197.8%
-2,158pp
Debt / equity
13.4×
+13.3×
Current ratio
6.5×
+1.3×
Watchlist
Screener
Filings
Earnings
Charts